Comment on: "A prospective randomized controlled trial comparing target prostate biopsy alone approach vs. target plus standard in naïve patients with positive mpMri"

Minerva Urol Nephrol. 2023 Apr;75(2):240-241. doi: 10.23736/S2724-6051.23.05308-9. Epub 2023 Mar 3.
No abstract available

Publication types

  • Randomized Controlled Trial
  • Comment

MeSH terms

  • Biopsy
  • Humans
  • Male
  • Multiparametric Magnetic Resonance Imaging*
  • Prospective Studies
  • Prostate / pathology
  • Prostate / surgery
  • Prostatic Neoplasms* / diagnosis
  • Prostatic Neoplasms* / pathology
  • Prostatic Neoplasms* / therapy